These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9876626)

  • 1. Effect of polysorbates on drug release from wax matrices.
    Dredán J; Zelkó R; Bihari E; Rácz I; Gondár E
    Drug Dev Ind Pharm; 1998 Jun; 24(6):573-6. PubMed ID: 9876626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of physicochemical properties of polyethylene glycol derivatives on drug release from wax matrices].
    Dredán J; Zelkó R; Bihari E; Rácz I
    Acta Pharm Hung; 1998 Jul; 68(4):210-3. PubMed ID: 9737020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting the formulation of sustained release potassium chloride tablets.
    Senel S; Capan Y; Hincal AA
    Pharmazie; 1991 Nov; 46(11):792-5. PubMed ID: 1811230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the wettability characteristics of polyethylene glycol derivatives on the drug release of wax matrices.
    Dredán J; Fekete R; Zelkó R; Rácz I; Marton S
    Pharmazie; 2000 Dec; 55(12):925-7. PubMed ID: 11189869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Process and formulation variables in the preparation of wax microparticles by a melt dispersion technique. I. Oil-in-water technique for water-insoluble drugs.
    Bodmeier R; Wang J; Bhagwatwar H
    J Microencapsul; 1992; 9(1):89-98. PubMed ID: 1613647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery.
    Miranda A; Millán M; Caraballo I
    Int J Pharm; 2006 Mar; 311(1-2):75-81. PubMed ID: 16446063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the preparation of sustained-release microspheres containing zedoary turmeric oil by the emulsion-solvent-diffusion method and evaluation of the self-emulsification and bioavailability of the oil.
    You J; Cui FD; Han X; Wang YS; Yang L; Yu YW; Li QP
    Colloids Surf B Biointerfaces; 2006 Mar; 48(1):35-41. PubMed ID: 16480856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine.
    Tanaka N; Imai K; Okimoto K; Ueda S; Tokunaga Y; Ohike A; Ibuki R; Higaki K; Kimura T
    J Control Release; 2005 Nov; 108(2-3):386-95. PubMed ID: 16253377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photoimages and the release characteristics of lipophilic matrix tablets containing highly water-soluble potassium citrate with high drug loadings.
    Cao QR; Kim TW; Lee BJ
    Int J Pharm; 2007 Jul; 339(1-2):19-24. PubMed ID: 17532156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.
    Reza MS; Quadir MA; Haider SS
    J Pharm Pharm Sci; 2003; 6(2):282-91. PubMed ID: 12935440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of shape factor on the release rate of drugs from lipid matrices.
    Ozdemir N; Karataş A
    Acta Pol Pharm; 1997; 54(5):353-6. PubMed ID: 9584692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained release phenylpropanolamine hydrochloride from ATO 888 matrix.
    Perez MA; Ghaly ES; Marti A
    P R Health Sci J; 1993 Dec; 12(4):263-7. PubMed ID: 8140204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination and interpretation of in vitro solubility behavior of pharmaceutical agents. 2. The effect of surface tension of the dissolution medium on the liberation of drugs in commercial preparations (tablets, dragees)].
    Bornschein M; Eitz K; Voigt R
    Pharmazie; 1987 Feb; 42(2):83-6. PubMed ID: 3602064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
    Yi T; Wan J; Xu H; Yang X
    Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets.
    Li FQ; Hu JH; Deng JX; Su H; Xu S; Liu JY
    Int J Pharm; 2006 Nov; 324(2):152-7. PubMed ID: 16837152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microencapsulated Eudragit RS30D-coated controlled-release pellets: the influence of dissolution variables and topographical evaluation.
    Govender T; Dangor CM; Chetty DJ
    J Microencapsul; 1997; 14(1):1-13. PubMed ID: 8994071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissolution and spectrophotometric determination of astaxanthin in aqueous solutions.
    Tichý E; Zabka M; Gardavská K; Halenárová A; Scheerová ZK; Potúcková M
    Pharmazie; 2011 Aug; 66(8):560-3. PubMed ID: 21901976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vivo and in vitro studies of the release of active ingredients in solid oral pharmaceutical preparations containing potassium chloride].
    Ekes G; Szentmiklósi P; Rácz I; Mezei J; Küttel S; Jancsó S
    Acta Pharm Hung; 1985 Sep; 55(5):163-7. PubMed ID: 4061085
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined effect of pH and polysorbates with cyclodextrins on solubilization of naringenin.
    Tommasini S; Calabrò ML; Raneri D; Ficarra P; Ficarra R
    J Pharm Biomed Anal; 2004 Oct; 36(2):327-33. PubMed ID: 15496325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.